A pilot trial of treprostinil for the treatment and prevention of digital ulcers in patients with systemic sclerosis.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 16635673.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We performed a pilot trial of subcutaneous treprostinil for the treatment of digital ulcers in scleroderma. Of the 5 patients completing therapy, ulcer size significantly decreased and no new ulcers occurred on continuous therapy. Although effective, the high rate of injection site reactions may limit the utility of this therapy.
Medical subject headings
- Epoprostenol
- Scleroderma, Systemic
- Skin Ulcer